CD55 is over-expressed in the tumour environment (Q41770177)

9 October 2017

CD55 is over-expressed in the tumour environment (English)

1 reference

9 October 2017

2

1 reference

9 October 2017

Li L

1

1 reference

9 October 2017

Morgan J

series ordinal

3

1 reference

9 October 2017

Durrant LG

series ordinal

4

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

British Journal of Cancer

9 October 2017

1 reference

9 October 2017

84

1 reference

9 October 2017

1

1 reference

9 October 2017

80-86

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1570

9 October 2017

0 references

cites work

Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Structure and function of decay accelerating factor CD55.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363604

A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55

6 June 2018

1 reference

12 December 2020

Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody

1 reference

12 December 2020

Hu Ly-m5: A unique antigen physically associated with HLA molecules

1 reference

12 December 2020

Localisation of human osteosarcoma by antitumour monoclonal antibody

1 reference

12 December 2020

The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours

1 reference

12 December 2020

Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36)

1 reference

12 December 2020

A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets

1 reference

12 December 2020

Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36

1 reference

12 December 2020

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody

1 reference

12 December 2020

Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7

1 reference

12 December 2020

Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion

1 reference

12 December 2020

Decay-accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C

1 reference

12 December 2020

Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells

1 reference

12 December 2020

From TCR Engagement to T Cell Activation

1 reference

12 December 2020

Decay accelerating factor (CD55): a target for cancer vaccines?

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1570

1 reference

Dimensions Publication ID

9 October 2017

0 references

1 reference

9 October 2017

1 reference